Survodutide Research Peptide

Product Overview

Survodutide is a synthetic dual glucagon receptor (GCGR) and GLP-1 receptor agonist peptide developed exclusively for laboratory and scientific investigations. It is widely studied in metabolic peptide biology, incretin signaling, receptor pharmacology, molecular biology, biotechnology, and experimental laboratory applications.

At BioWellLab UK, every batch of Survodutide is manufactured under stringent quality standards and undergoes comprehensive analytical testing to verify identity, purity, and batch-to-batch consistency before release.

Supplied in 10mg lyophilized vials, Survodutide enables researchers to conduct laboratory investigations involving dual receptor signaling pathways and metabolic peptide research using a highly purified research-grade compound.

Researchers frequently compare Survodutide with Retatrutide, Tirzepatide, and Semaglutide in laboratory studies involving incretin biology, glucagon receptor signaling, and metabolic research. Additional research peptides are available throughout the BioWellLab Shop.

This product is supplied strictly for laboratory and scientific research purposes and is not intended for human consumption or veterinary use.

Research Applications

Survodutide is commonly investigated in laboratory studies involving:

• GLP-1 receptor biology
• Glucagon receptor (GCGR) biology
• Dual receptor signaling
• Metabolic peptide research
• Receptor pharmacology
• Molecular biology
• Cell biology
• Biotechnology research
• Experimental pharmacology
• Preclinical laboratory research

Product Specifications

Quality Assurance

Every BioWellLab research peptide is manufactured under rigorous quality standards and tested using validated analytical techniques, including High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography–Mass Spectrometry (LC-MS) where applicable. Each production batch is verified for purity, identity, and batch-to-batch consistency before release and is accompanied by a Certificate of Analysis (COA).

Certificates of Analysis are available upon request for supported product batches.

Storage

Store unopened vials at -20°C in a clean, dry laboratory environment. Protect from moisture, excessive heat, and direct sunlight. Avoid repeated freeze–thaw cycles after reconstitution and follow standard laboratory handling procedures.

Frequently Asked Questions

What is Survodutide?

Survodutide is a synthetic dual glucagon receptor (GCGR) and GLP-1 receptor agonist peptide supplied exclusively for laboratory investigations involving metabolic peptide biology, receptor pharmacology, and molecular research.

What strength is available?

BioWellLab supplies Survodutide in 10mg lyophilized vials.

What purity does BioWellLab provide?

Every production batch is analytically tested to verify a purity of greater than 99% before release.

Is this product intended for human use?

No. Survodutide supplied by BioWellLab UK is intended strictly for laboratory research and must not be used for human consumption or veterinary applications.

Scientific Resources

Researchers seeking additional scientific information can explore the following resources:

• NCBI PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Survodutide
• PubChem: https://pubchem.ncbi.nlm.nih.gov/
• EMBL-EBI: https://www.ebi.ac.uk/
• UniProt: https://www.uniprot.org/
• IUPHAR Guide to Pharmacology: https://www.guidetopharmacology.org/

Research Use Only

Survodutide supplied by BioWellLab UK is intended exclusively for laboratory, analytical, and scientific research purposes. This product is not intended to diagnose, treat, cure, or prevent any disease and must not be used for human or veterinary applications. It should only be handled by qualified professionals in appropriate laboratory settings.